Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin II type I receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry—National Institute of Health

BACKGROUND: Selecting angiotensin converting enzyme inhibitor (ACEI) or angiotensin II type I receptor blocker (ARB) in patients diagnosed as acute myocardial infarction (AMI) with non-obstructive coronary arteries (MINOCA) is not established. The purpose of this study is to compare the clinical eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Joon Ho, Hyun, Ju Yong, Jeong, Myung Ho, Kim, Ju Han, Hong, Young Joon, Sim, Doo Sun, Kim, Min Chul, Park, Hun-Sik, Kim, Doo-Il, Hur, Seung-Ho, Oh, Seok Kyu, Ahn, Youngkeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2020
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428933/
https://www.ncbi.nlm.nih.gov/pubmed/33001422
http://dx.doi.org/10.5603/CJ.a2020.0130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428933/
https://www.ncbi.nlm.nih.gov/pubmed/33001422
http://dx.doi.org/10.5603/CJ.a2020.0130

Ejemplares similares